Escherichia coli can ameliorate the toxic effects of alkylating agents either by preventing DNA alkylation or by repairing DNA alkylation damage. The alkylation-sensitive phenotype ofE. coli alkB mutants marks the alkB pathway as an extremely effective defense mechanism against the cytotoxic effects of the SN2, but not the SN1, alkylating agents. Although it is clear that AlkB helps cells to better handle alkylated DNA, no DNA alkylation repair function could be assigned to the purified AlkB protein, suggesting that AlkB either acts as part of a complex or acts to regulate the expression of other genes whose products are directly responsible for alkylation resistance. However, here we present evidence that the provision of alkylation resistance is an intrinsic function of the AlkB protein per se. We expressed the E. coli AlkB protein in two human cell lines and found that it confers the same characteristic alkylation-resistant phenotype in this foreign environment as it does in E. coli. AlkB expression rendered human cells extremely resistant to cell killing by the SN2 but not the SN1 alkylating agents but did not affect the ability of dimethyl sulfate (an SN2 agent) to alkylate the genome. We infer that SN2 agents produce a class of DNA damage that is not efficiently produced by SN1 agents and that AlkB somehow prevents this damage from killing the cell.
The alkylation of DNA nitrogens and oxygens causes cell death and mutation in Eschenchia coli and in every cell type studied to date (8, 19) . The commonly studied alkylating agents, N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), methylnitrosourea (MNU), methyl methanesulfonate (MMS), and dimethyl sulfate (DMS), all produce the same collection of a dozen different alkylated lesions in DNA (32) . However, because these agents alkylate DNA via different mechanisms, they produce the lesions in different proportions (18) . MMS and DMS react via a SN2 mechanism and alkylate predominantly at DNA base nitrogens, producing very little alkylation at the oxygens in DNA bases and the oxygens in the sugarphosphate backbone. In contrast, MNNG and MNU react via an SN1 mechanism and efficiently alkylate both nitrogens and oxygens in DNA (7, 32) .
E. coli has several pathways that specifically ameliorate the toxic and mutagenic effects of DNA alkylation damage, and the absence of these pathways renders cells specifically sensitive to alkylating agents. Two DNA methyltransferases (MTases) encoded by the ada and ogt genes transfer methyl groups from various oxygens in DNA to an active-site cysteine residue in each of the MTase proteins. The Ada and Ogt MTases transfer methyl groups from 06-methylguanine (O6MeG) and 04-methylthymine (O4MeT); since O6MeG and O4MeT mispair during DNA replication, their repair protects E. coli from alkylation-induced mutation (19, 25) . The Ada MTase also transfers methyl groups from methylphosphotriester DNA lesions to a second active-site cysteine residue, whereupon the Ada protein is transformed into an efficient transcriptional activator for the ada, alkA4, alkB, and aidB genes (19, 34, 38) .
Thus, methylphosphotriester lesions in the E. coli genome signal the induced expression of at least four genes, including the ada MTase gene itself. This response is known as the 02-methylpyrimidine lesions from DNA (19) . 3-Methyladenine (3MeA) lesions block E. coli DNA replication, and their repair by the AlkA glycosylase (and by another DNA glycosylase constitutively produced from the tag gene) specifically prevents alkylation-induced cell death. The precise functions of the alkB and aidB gene products are not known, but what is known about AlkB is summarized below.
The E. coli alkB gene lies downstream from and forms an operon with the ada gene; alkB transcription is therefore regulated as part of the adaptive response to alkylating agents (19) . E. coli alkB mutant cells are extremely sensitive to the toxic effects of MMS, an SN2 alkylating agent, but are only slightly sensitive to MNNG, an SN1 alkylating agent (16) . The fact that the absence of a functional alkB gene decreases the ability of E. coli to support the growth of MMS-treated bacteriophage lambda indicates that AlkB does not act to prevent MMS-induced DNA alkylation but, rather, allows cells to better handle MMS-alkylated DNA (16) . Genetic experiments indicate that the functions of AlkB do not overlap with those of the AlkA 3MeA DNA glycosylase (37) . The alkB gene has been cloned and sequenced, and the 27-kDa AlkB protein has been purified to homogeneity (15, 17) ; however, in vitro assays have not yet revealed any DNA repair functions for the purified AlkB protein (15, 17) . Failure to identify an enzymatic activity for the purified AlkB protein would be expected if AlkB acts as part of a multiprotein complex or if AlkB acts to regulate the expression of another E. coli gene whose product repairs DNA alkylation damage. In this study we present evidence against both of these possibilities.
Three prokaryotic DNA repair genes were previously introduced into mammalian cells, and their expression confers resistance to DNA-damaging agents. These are the T4 UV endonuclease (denV) gene (2, 35, 36) , which provides UV resistance, and the E. coli ada (3, 5, 11, 14, 28) and ogt (9, 39) genes, which provide alkylation resistance. Notably, DenV, MTase) were gifts from R. B. Setlow, Brookhaven National Laboratories. HeLa cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 100 ,xg of streptomycin per ml, 100 U of penicillin per ml, and 0.03% L-glutamine and incubated in humidified 5% CO2 at 370C.
Plasmids. We cloned the adiB gene under the Rous sarcoma virus (RSV) long terminal repeat (LTR) promoter in the pRSV plasmid (from Invitrogen) to produce pRSValkB, whose structure is shown in Fig. 1 . Plasmid p500 (10) was a gift from Mutsuo Sekiguchi, Kyushu University, Fukuoka, Japan, and was used to construct pSOOalkB, which also has the alkB gene under the RSV LTR promoter (Fig. 1) . Note that the RSV LTR promoter will direct transcription in both E. coli and mammalian cells (1) . Restriction endonucleases and T4 DNA ligase were from New England Biolabs, and E. coli HB101 was used as the bacterial host for the plasmids.
Transfections. HeLa cells were seeded at 106 cells per 100-mm dish on day 1. On day 2, 12 pg of p500 or p5OOalkB was transfected into these cells by the calcium phosphate method (33) . Transfectants were selected in 200 to 300 pug of hygromycin B per ml from day 6 onwards (4), and transfectants were isolated either as pools of about 50 transfectants or as individual clones (see text).
Western imnmunoblot analysis. Rabbit polyclonal antibodies were raised against a mixture of two octapeptides (conjugated to keyhole limpet hemocyanin) deduced from the alkB gene sequence to represent the amino-and carboxyl-terminal ends of the AlkB protein; the sequences of these peptides were NH2-Met-Leu-Asp-Leu-Phe-Ala-Asp-Ala-(Cys)-COOH and NH2-(Cys)-Phe-Arg-Gln-Ala-Gly-Lys-Glu-COOH (the Cys residues were added for conjugation to keyhole limpet hemacyanin, with N-succinimidyl bromoacetate as a cross-linking reagent). Cell extracts were prepared, as previously described, from bacteria (21) and HeLa cells (29) . Extract proteins (2O-p~g samples) were separated by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (12% acrylamide), blotted onto nitrocellulose, and probed in 3% low-fat dry milk with across agar plates containing an MMS gradient. All experiments were repeated at least three times, the data were very reproducible, and a representative curve is presented. For the E. coli colony-forming assay, cells were grown at 37C with aeration to a density of 108 cells per ml in Luria-Bertani (LB) medium (20) , alkylating agent was added to the indicated concentration, and aliquots were removed at the indicated times, diluted, and spread on LB agar plates. Colonies were counted 24 h later, and survival was expressed as a percentage of colonies at the zero dose. For the measurement of relative sensitivities by growth on MMS gradient plates (22), 30 ml of molten LB agar (1.5%) containing 0.02% MMS was poured into a square petri dish angled such that the agar solidified into a wedge but covered the entire bottom of the plate; the plate was leveled, and another 30 ml of LB agar (without MMS) was added. Once the agar had set, cells were streaked across the gradient (the thick end of the MMS-agar wedge providing the highest MMS dose). Growth was monitored after a 24-h incubation at 370C. For the HeLa cell colony-forming assay, 100-mm tissue culture dishes were seeded with 500, 5,000, or 50,000 cells in 10 ml of medium. For MNNG and MNU treatments, the agents were diluted in 100 mM acetate buffer (pH 5.0) and immediately added to the dishes. For MMS and DMS treatments, the cells were left for 24 h to attach to the plates, washed with phosphate-buffered saline (PBS), and refed with serum-free medium containing MMS or DMS at the E. COLI AlkB PROTEIN 6257 indicated concentrations. After 1 h, the alkylating agentcontaining medium was aspirated and the cells were washed with PBS and then refed with serum-containing medium. After a 12-day incubation, colonies were fixed and stained. The colony-forming efficiency was expressed as a percentage of colonies at the zero dose.
SCE determinations. Sister chromatid exchange (SCE) induction was measured as described previously (29) . Briefly, 1 X 106 to 2 X 106 HeLa cells were seeded in 150-cm2 flasks, left for 24 h for the cells to attach, and then exposed to MMS at the indicated doses for 1 h in serum-free medium. The cells were then cultured for two rounds of DNA replication (2 days) in medium containing 10 RM bromodeoxyuridine. Mitotic cells were collected, stained, and scored for SCEs as described previously (26 (16) , nor are they sensitive to agents that produce oxidative DNA damage (data not shown), suggesting that the AIkB protein specifically protects againstalkylating agents. It was also noted that alkB mutants were not very sensitive to MNNG-induced cell killing, and it was inferred that sensitivity was more profound for SN2 than for SN1 alkylating agents (16) . We have confirmed this assumption by testing the sensitivity of alkB mutants to two other alkylating agents, namely MNU and DMS, which are SN1 and SN2 alkylating agents, respectively. While the alkB mutant was only slightly sensitive to MNU, it was extremely sensitive to DMS, supporting the conclusion that the AlkB protein mainly protects E. ccli against SN2-type alkylating agents ( Fig. 2A) .
That the AlkA 3MeA DNA glycosylase and the AlkB protein protect against MMS-induced cell killing via different pathways was inferred from the following two observations: (i) the purified AlkB protein lacks 3MeA DNA glycosylase activity (17) , and (ii) alkA alkB double mutants display a degree of MMS sensitivity that roughly equals the sum of that seen for alkA and alkB single mutants (37 (27) .
To date, no DNA alkylation repair function has been assigned to the AlkB protein (5a, 17). It agents, (ii) it is not a 3MeA DNA glycosylase, and (iii) it is likely to act by enabling E. coli to better handle DNA alkylation damage rather than by preventing DNA alkylation damage.
Expression of the E. coil AAR protein in human cells. To determine whether the AlkB protein can function in the absence of other E. coli proteins (with which it may complex) or in the absence of other E. coi genes (which it may regulate), we set out to determine whether it can function in mammalian cells. The E. coli alkB gene was cloned under the RSV LTR promoter in two mammalian expression vectors, pRSV and p500, to produce pRSValkB and pSOOalkB, respectively (see Materials and Methods) (Fig. 1) . The RSV LTR promoter was chosen because it promotes transcription in E. coli as well as mammalian cells (1) , making it possible to confirm that each construct produced functional ALkB protein by checking its ability to confer MMS resistance upon E. coli alkB mutants ( Fig. 2 and data not shown) . Our efforts to express the AlkB protein in human cells from the pRSValkB construct proved unsuccessful (data not shown), but, as described below, the p5OOalkB construct produced significant levels of AlkB in two different HeLa cell lines. We attribute this difference to the fact that, unlike pRSValkB, the pSOOalkB plasmid can replicate autonomously in HeLa cells, making it easier to isolate transfectants harboring many copies of the alkB gene (40) .
We chose to express the AlkB protein in an alkylationsensitive human cell line (HeLa S3 Mer-) and an alkylationresistant human cell line (HeLaCCL2 Mere); the different alkylation sensitivities have been attributed to the expression of the O6MeG DNA MTase (MGMT) gene in Mer' cells and the lack of MGMT expression in Mer-cells (7, 12, 23 (Fig. 3) . These cell lines were used to determine whether A&kB could confer an alkylation-resistant phenotype in the absence of other E. coli genes and proteins.
Alkylation sensitivity of A&kB-expressing human cells. The sensitivity of the AlkB-expressing HeLa cell lines to SN1 and SN2 alkylating agents is shown in Fig. 4 and 5. For both the HeLa S3 (Fig. 4) and HeLa CCL2 (Fig. 5) cell lines, the ALkB protein conferred extensive resistance to the SN2-type alkylating agents (MMS and DMS) but did not confer resistance to the SN1-type alkylating agents (MNNG and MNU) or to a more complex alkylating agent, namely NN'-bis(2-chloroethyl)-N-nitrosourea (BCNU). In other words, the E. coli AlkB protein confers the same characteristic alkylation-resistant phenotype in human cells as it does in its natural environment. Surprisingly, even though ALkB could prevent the cell-killing effects of MMS, it was unable to prevent the SCE-inducing effects of this agent (Fig. 6) .
Does the E. colt AlkB protein prevent DNA alkylation in 
DISCUSSION
The alkylation-sensitive phenotype of E. coli alkB mutants identifies the alkB pathway as an important and highly effective cellular defense mechanism against the toxic effects of the SN2-type alkylating agents. However, despite the isolation and characterization of the alkB gene and the purified AlkB protein (15, 17) , the mechanism by which AlkB functions remains elusive. It thus seemed possible that the AlkB protein itself is not solely responsible for alkylation resistance, perhaps because it exerts its effects as part of a complex with other proteins or by regulating the expression of other genes. We therefore sought to determine whether AlkB was able to provide alkylation resistance in the absence of other E. coli genes and proteins, by asking whether AlkB could function in a foreign environment, namely in human cells. While it formally remains possible that AlkB forms a functional complex with human proteins or acts to regulate the expression of human genes, we believe this to be highly unlikely. Thus, the observation that the E. coli AlkB protein confers the same characteristic alkylation-resistant phenotype upon human cells as it does upon E. coli strongly suggests that the provision of alkylation resistance is an intrinsic function of the AlkB protein per se.
We determined whether AlkB could confer alkylation resistance in both the alkylation-sensitive Mer- (19, 24, 30) . The overexpression of metallothionein in mammalian cells confers resistance to the SN1 but not the SN2 alkylating agents, but this occurs via an unknown mechanism that appears not to involve either the prevention or the repair of DNA alkylation damage (13) . The 
